C‐Reactive Protein Level as a Novel Serum Biomarker in Sarcopenia
Mediators of Inflammation · 2024
DOI: 10.1155/2024/3362336 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediators of Inflammation, 2024. Verfasst von Shangjin Lin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China. Hauptthemen laut MEDLINE: Sarcopenia, C-Reactive Protein, Biomarkers, Hand Strength. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
The role of C‐reactive protein (CRP), an inflammatory marker, in the development of sarcopenia remains uncertain.
Methods
This cross‐sectional research involved the enrollment of 207 patients, classified into two groups: 74 patients with sarcopenia and 133 patients without sarcopenia. Clinical data of the participants, including hand grip strength, walking speed, appendicular lean mass (ALM), and calf circumference, were collected and recorded. We evaluated the extent to which CRP levels are associated with the risk of sarcopenia using both univariate and multivariate logistic regression models. Besides, the correlation between CRP levels, hand grip strength, ALM, and walking speed was examined using the Spearman rank correlation test. Moreover, we have employed the Mendelian randomization (MR) analysis technique to explore the causal relationship between CRP levels and the occurrence of sarcopenia.
Results
The sarcopenia group showed a higher proportion of older women, with significant differences in anemia prevalence, calf circumference, gait speed, ALM, hand grip strength, and elevated CRP levels compared to the control group. Logistic regression analyses identified CRP as an independent risk factor for sarcopenia (OR: 1.151, 95% CI:1.070−1.238, and P < 0.001). Correlation analysis results revealed a noteworthy inverse association with hand grip strength ( R = −0.454 and P < 0.001), ALM ( R = −0.426 and P < 0.001), and walking speed ( R = −0.431 and P < 0.001). MR analysis provided further evidence of a significant detrimental link between genetically predicted CRP levels and essential sarcopenia characteristics, with consistent results across various statistical models.
Conclusions
Our study uncovered strong evidence supporting a noteworthy inverse association and causality between CRP concentrations and sarcopenia, indicating that CRP has the potential to serve as a biomarker for sarcopenia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
- Shanghai Key Laboratory of Clinical Geriatric Medicine, Shanghai 200040, China.
- Department of Gerontology Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
- Department of Gastroenterology Huadong Hospital Affiliated to Fudan University, Shanghai 200040, China.
ORCID-Profile: Fengjian Yang, Zhijun Bao, Yongqian Fan
Zitieren
APA
Lin, S., Chen, X., Cheng, Y., Huang, H., Yang, F., Bao, Z., & Fan, Y. (2024). C‐Reactive Protein Level as a Novel Serum Biomarker in Sarcopenia. Mediators of Inflammation. https://doi.org/10.1155/2024/3362336
Vancouver
Lin S, Chen X, Cheng Y, Huang H, Yang F, Bao Z, et al. C‐Reactive Protein Level as a Novel Serum Biomarker in Sarcopenia. Mediators of Inflammation. 2024. doi:10.1155/2024/3362336
BibTeX
@article{Lin2024,
author = {Lin, Shangjin and Chen, Xiuxiu and Cheng, Ying and Huang, Hou and Yang, Fengjian and Bao, Zhijun and Fan, Yongqian},
title = {C‐Reactive Protein Level as a Novel Serum Biomarker in Sarcopenia},
journal = {Mediators of Inflammation},
year = {2024},
doi = {10.1155/2024/3362336}
}
EUVIMED